Skip to main content

Advertisement

SpringerLink
Log in

Uric acid nephrolithiasis

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Uric acid nephrolithiasis is typically found in individuals with a low urine pH and a normal concentration of urinary uric acid. Patients with a history of gout are at greater risk of forming uric acid stones, as are patients with obesity, diabetes, or the complete metabolic syndrome. The unifying renal tubular abnormality of these disorders appears to be the excretion of abnormally acidic urine. This article focuses on the relationship of these disorders to the development of uric acid stones. The diagnosis of uric acid stones can be elusive, because pure uric acid stones are radiolucent on plain radiographs. Ultrasound, or preferably noncontrast helical CT scanning, is required for their detection. The treatment of uric acid stones should focus on alkalinization of the urine with citrate or bicarbonate salts. Additional interventions such as increase in fluid intake and decrease in animal protein ingestion are often beneficial. Patients with documented hyperuricemia often require specific therapy to lower serum uric acid concentration and subsequent excretion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Monk RD, Bushinsky DA: Kidney stones. In Williams Textbook of Endocrinology, edn 10. Edited by Larsen PR, Kronenberg HM, Melmed S, Polonsky KS. Philadelphia: W.B. Saunders; 2003:1411–1425.

    Google Scholar 

  2. Monk RD, Bushinsky DA: Nephrolithiasis and nephrocalcinosis. In Comprehensive Clinical Nephrology, edn 2. Edited by Johnson R, Frehally J. London: Mosby; 2003:731–744.

    Google Scholar 

  3. Coe FL, Evan A, Worcester E: Kidney stone disease. J Clin Invest 2005, 115:2598–2608.

    Article  PubMed  CAS  Google Scholar 

  4. Bushinsky DA: Kidney stones. Adv Intern Med 2001, 47:219–238.

    PubMed  CAS  Google Scholar 

  5. Shekarriz B, Stoller ML: Uric acid nephrolithiasis: current concepts and controversies. J Urology 2002, 168:1307–1314.

    Article  CAS  Google Scholar 

  6. Wortmann RL, Kelley WN: Gout and hyperuricemia. In Kelley’s Textbook of Rheumatology, edn 7. Edited by Harris E, Budd R, Genovese M, et al. Philadelphia: Elsevier Saunders; 2005:1402–1429.

    Google Scholar 

  7. Choi HK, Curhan G: Gout: epidemiology and lifestyle choices. Curr Opin Rheumatol 2005, 17:341–345.

    Article  PubMed  Google Scholar 

  8. Kramer HJ, Choi HK, Atkinson K, et al.: The association between gout and nephrolithiasis in men: The Health Professionals’ Follow-Up Study. Kidney Int 2003, 64:1022–1026.

    Article  PubMed  Google Scholar 

  9. Terkeltaub R, Bushinsky D, Becker M: Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics. Arthritis Res Ther 2006, 8:S4.

    Article  PubMed  CAS  Google Scholar 

  10. Daudon M, Traxer O, Conort P, et al.: Type 2 diabetes increase the risk for uric acid stones. J Am Soc Neph 2006, 17:2026–2033.

    Article  CAS  Google Scholar 

  11. Taylor EN, Stampfer MJ, Curhan GC: Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 2005, 68:1230–1235.

    Article  PubMed  Google Scholar 

  12. Cameron MA, Maalouf NM, Adams-Huet B, et al.: Urine composition in type 2 diabetes: predispostiion to uric acid nephrolithiasis. J Am Soc Neph 2006, 17:1422–1428.

    Article  CAS  Google Scholar 

  13. Yu TF, Gutman AB: Uric acid nephrolithiasis in gout. Ann Intern Med 1967, 67:1133–1148.

    PubMed  CAS  Google Scholar 

  14. Taylor EN, Stampfer MJ, Curhan GC: Obesity, weight gain, and the risk of kidney stones. JAMA 2005, 293:455–462.

    Article  PubMed  CAS  Google Scholar 

  15. Alvarez-Nemegyei J, Medina-Escobedo M, Villanueva-Jorge S, Vasquez-Mellado J: Prevalence and risk factors for urolithiasis in primary gout: is a reappraisal needed? J Rheumatol 2005, 32:2189–2191.

    PubMed  CAS  Google Scholar 

  16. Wallace S, Robinson H, Masi A, et al.: Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977, 20:895–900.

    Article  PubMed  CAS  Google Scholar 

  17. Kramer H, Curhan G: The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988–1994. Am J Kidney Dis 2002, 40:37–42.

    Article  PubMed  Google Scholar 

  18. Sakhaee K, Adams-Huet B, Moe OW, Pak CY: Pathyophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int 2002, 62:971–979.

    Article  PubMed  CAS  Google Scholar 

  19. Moe OW, Abate N, Sakhaee K: Pathophysiology of uric acid nephrolithiasis. Endo Clin North Am 2002, 31:895–914.

    Article  CAS  Google Scholar 

  20. Mount DB, Kwon C, Zandi-Nejad K: Renal urate transport. Rheumatic Disease Clinics of North America 2006, 32:313–331.

    Article  PubMed  Google Scholar 

  21. Enomoto A, Kimura H, Chairoungdua A, et al.: Molecular identification of a renal urate-anion exchanger that regulates blood urate levels. Nature 2002, 417:447–452.

    PubMed  CAS  Google Scholar 

  22. Pak CY, Sakhaee K, Peterson RD, et al.: Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int 2001, 60:757–761.

    Article  PubMed  CAS  Google Scholar 

  23. Henneman PH, Wallach S, Dempsey EF: The metabolic defect responsible for uric acid stone formation. J Clin Invest 1962, 41:537–542.

    Article  PubMed  CAS  Google Scholar 

  24. Asplin JR: Uric acid stones. Semin Nephrol 1996, 16:412–424.

    PubMed  CAS  Google Scholar 

  25. Khatchadourian J, Preminger GM, Whitson PA, et al.: Clinical and biochemical presentation of gouty diathesis: comparison of uric acid versus pure calcium stone formation. J Urol 1995, 154:1665–1669.

    Article  PubMed  CAS  Google Scholar 

  26. Lennon EJ, Lemann J, Jr., Litzow JR: The effects of diet and stool composition on the net external acid balance of normal subjects. J Clin Invest 1966, 45:1601–1607.

    PubMed  CAS  Google Scholar 

  27. Kurtz I, Maher T, Hulter HN, et al.: Effect of diet on plasma acid-base composition in normal humans. Kidney Intl 1983, 24:670–680.

    Article  CAS  Google Scholar 

  28. Abate N, Chandalia M, Cabo-Chan AV, et al.: The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kid Int 2004, 65:386–392.

    Article  CAS  Google Scholar 

  29. Pak CY, Sakhaee K, Moe O, et al.: Biochemical profile of stone-forming patients with diabetes mellitus. Urology 2003, 61:523–527.

    Article  PubMed  Google Scholar 

  30. Pak CY, Poindexter JR, Peterson RD, et al.: Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis. Urology 2002, 60:789–794.

    Article  PubMed  Google Scholar 

  31. Hediger MA, Johnson RJ, Miyazaki H, Endou H: Molecular physiology of urate transport. Physiology 2005, 20:125–133.

    Article  PubMed  CAS  Google Scholar 

  32. Daudon M, Lacour B, Jungers P: Influence of body size on urinary stone composition in men and women. Urol Res 2006, 34:193–199.

    Article  PubMed  Google Scholar 

  33. Maalouf NM, Sakhaee K, Parks JH, et al.: Association of urinary pH with body weight in nephrolithiasis. Kidney Int 2004, 65:1422–1425.

    Article  PubMed  Google Scholar 

  34. Maalouf NM, Cameron MA, Moe OW, Sakhaee K: Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens 2004, 13:181–189.

    Article  PubMed  Google Scholar 

  35. Bloomgarden ZT.: Measures of insulin sensitivity. Clin Lab Med 2006, 26:611–633.

    Article  PubMed  Google Scholar 

  36. Chobanian MC, Hammerman MR: Insulin stimulates ammoniagenesis in canine renal proximal tubular segments. Am J Physiol 1987, 253:F1171–F1177.

    PubMed  CAS  Google Scholar 

  37. Nissim I, States B, Nissim I, et al.: Hormonal regulation of glutamine metabolism by OK cells. Kidney Int 1995, 47:96–105.

    Article  PubMed  CAS  Google Scholar 

  38. Davidson MB, Thakkar S, Hix JK, et al.: Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. Am J Med 2004, 116:546–554.

    Article  PubMed  CAS  Google Scholar 

  39. Sica D, Schoolwerth AC: Part 1. Uric acid and losartan. Curr Opinion Nephrol Hyperten 2002, 11:475–482.

    Article  Google Scholar 

  40. Feher MD, Hepburn AL, Hogarth MB, et al.: Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout. Rheumatology (Oxford) 2003, 42:321–325.

    Article  CAS  Google Scholar 

  41. Milionis HJ, Kakafika AI, Tsouli SG, et al.: Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. Am Heart J 2004, 148:635–640.

    Article  PubMed  CAS  Google Scholar 

  42. Clive DM: Renal transplant-associated hyperuricemia and gout. J Am Soc Nephrol 2000, 11:974–979.

    PubMed  CAS  Google Scholar 

  43. Worster A, Preyra I, Weaver B, Haines T: The accuracy of noncontrast helical computed tomography versus intravenous pyelography in the diagnosis of suspected acute urolithiasis: A meta-analysis. Ann Emerg Med 2002, 40:280–286.

    Article  PubMed  Google Scholar 

  44. Coe FL, Favus MJ, Asplin JR: Nephrolithiasis. In The Kidney, edn 7. Edited by Brenner BM. Philadelphia: W.B. Saunders Company; 2004:1819–1866.

    Google Scholar 

  45. Burns J, Gauthier JF, Finlayson B: Dissolution kinetics of uric acid calculi. J Urol 1984, 131:708–711.

    PubMed  CAS  Google Scholar 

  46. Borghi L, Meschi T, Amato F, et al.: Urinary volume, water, and recurrences in idiopathic calcium nephrolithiasis: A 5-year randomized prospective study. J Urol 1996, 155:839–843.

    Article  PubMed  CAS  Google Scholar 

  47. Lemann J Jr, Bushinsky DA, Hamm LL: Bone buffering of acid and base in humans. Am J Physiol Renal Physiol 2003, 285:F811–F832.

    PubMed  CAS  Google Scholar 

  48. Pais VM Jr, Lowe G, Lallas CD, et al.: Xanthine urolithiasis. Urology 2006, 67:1084–2011.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nephrology Division, Strong Memorial Hospital, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 675, Rochester, NY, 14642, USA

    Scott E. Liebman MD

Authors
  1. Scott E. Liebman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeremy G. Taylor MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David A. Bushinsky MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Scott E. Liebman MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liebman, S.E., Taylor, J.G. & Bushinsky, D.A. Uric acid nephrolithiasis. Curr Rheumatol Rep 9, 251–257 (2007). https://doi.org/10.1007/s11926-007-0040-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-007-0040-z

Keywords

Search

Navigation